Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Zoeken op expertise, naam of affiliatie
Prevalence of human respiratory syncytial virus circulating in Iran
Vahid Salimi
, Masoumeh Tavakoli-Yaraki
, Jila Yavarian
,
Louis Bont
, Talat Mokhtari-Azad
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel recenseren
›
peer review
38
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Prevalence of human respiratory syncytial virus circulating in Iran'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Respiratory Syncytial Virus
100%
Iran
100%
Human Respiratory Syncytial Virus (hRSV)
100%
Respiratory Syncytial Virus Infection
50%
Virus Genotype
33%
Molecular Epidemiology
33%
Meta-analysis
16%
Clinical Characteristics
16%
Surveillance Program
16%
Novel Therapeutics
16%
Epidemiological Characteristics
16%
Genotype
16%
Early childhood
16%
Male-to-female Ratio
16%
Acute Respiratory Infection
16%
Genotype Distribution
16%
Pathological Characteristics
16%
Phase II Clinical Trial
16%
Respiratory Syncytial Virus Vaccines
16%
Virus Surveillance
16%
Molecular Surveillance
16%
Surveillance Data
16%
Cell Entry
16%
Phylogenetic Study
16%
Virus Prevalence
16%
Cold Season
16%
Prevalence Distribution
16%
Entry Inhibitor
16%
Therapeutic Good
16%
Respiratory Specimens
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
42%
Molecular Epidemiology
28%
Clinical Trial
14%
Respiratory Tract Infection
14%
Respiratory Syncytial Virus Vaccine
14%
Fusion Inhibitor
14%
Immunology and Microbiology
Prevalence
100%
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
42%
Molecular Epidemiology
28%
Phylogeny
14%
Respiratory Syncytial Virus Vaccine
14%
Virus Surveillance
14%
Cladistics
14%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Human Respiratory Syncytial Virus
100%
Clinical Trial
9%
Phylogeny
9%
Genotyping
9%
Cladistics
9%